Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.pastori@uniroma1.it
Daniele Pastori
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE MEDICHE E CARDIOVASCOLARI
E-mail:
daniele.pastori@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
2023
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease: A comprehensive systematic-review and meta-analysis
THROMBOSIS RESEARCH
2023
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
2023
Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium?
AMERICAN HEART JOURNAL
2023
Venous Thromboembolism in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,170,027 Patients
2023
Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation. impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients
THROMBOSIS AND HAEMOSTASIS
2022
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2022
Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study
THROMBOSIS RESEARCH
2022
Plasma homocysteine in Behcet's disease: a systematic review and meta-analysis
THROMBOSIS AND HAEMOSTASIS
2022
REPLY to “Association Between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome”
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2022
Added fructose in non-alcoholic fatty liver disease and in metabolic sindrome. a narrative review
NUTRIENTS
2022
A Meta-Analysis of Plasma Homocysteine in Buerger's Disease
THROMBOSIS AND HAEMOSTASIS
2022
Thrombotic aspects of SARS-CoV-2 infection: indications for treatment
ITALIAN JOURNAL OF EMERGENCY MEDICINE
2022
Aging-Related Decline of Autophagy in Patients with Atrial Fibrillation—A Post Hoc Analysis of the ATHERO-AF Study
ANTIOXIDANTS
2022
Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
NUTRIENTS
2022
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease
BIOMEDICINES
2022
Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. Insights from the nationwide PLECTRUM registry
PLATELETS
2022
Clinical phenotypes of atrial fibrillation and mortality risk-a cluster analysis from the nationwide italian START registry
JOURNAL OF PERSONALIZED MEDICINE
2022
Fibrosis-4 (FIB-4) index and mortality in COVID-19 patients admitted to the emergency department
INTERNAL AND EMERGENCY MEDICINE
2022
Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. the multicenter ATHERO-APS study
JOURNAL OF AUTOIMMUNITY
2022
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
…
seguente ›
ultima »
ERC
LS4
LS4_10
LS7
LS7_10
Keywords
cardiovascular disease
anticoagulation
Novel oral anticoagulants
atrial fibrillation
atherosclerosis
NAFLD
NASH
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk
Thrombosis
Atherothrombosis
Progetti di Ricerca
Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma